(Q53250185)

12 May 2018

title

Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease. (English)

1 reference

12 May 2018

1 reference

2

1 reference

12 May 2018

Wolfgang H. Oertel

14

Wolfgang H Oertel

1 reference

12 May 2018

12

Hans-Jürgen Möller

1 reference

12 May 2018

9

Katharina Buerger

1 reference

12 May 2018

Richard Dodel

1

Richard Dodel

1 reference

12 May 2018

Xing Wei

8

Xing Wei

1 reference

12 May 2018

Martin R. Farlow

13

Martin Farlow

1 reference

12 May 2018

author name string

Candan Depboylu

3

1 reference

12 May 2018

Suizhen Lin

4

1 reference

12 May 2018

Feng Gao

5

1 reference

12 May 2018

Sabine Schock

6

1 reference

12 May 2018

Steffi Jäckel

7

1 reference

12 May 2018

Christine Höft

10

1 reference

12 May 2018

Bernhard Hemmer

11

1 reference

12 May 2018

Norbert Sommer

15

1 reference

12 May 2018

Yansheng Du

16

1 reference

12 May 2018

publication date

1 August 2002

1 reference

12 May 2018

published in

Annals of Neurology

1 reference

12 May 2018

volume

52

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

253-256

1 reference

12 May 2018

Translating cell biology into therapeutic advances in Alzheimer's disease

cites work

1 reference

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer

21 January 2018

1 reference

Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus

21 January 2018

1 reference

Biology of A beta amyloid in Alzheimer's disease

21 January 2018

1 reference

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

21 January 2018

1 reference

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

Reduced levels of amyloid beta-peptide antibody in Alzheimer disease

21 January 2018

1 reference

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

21 January 2018

1 reference

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs

21 January 2018

1 reference

Human antibodies reactive with beta-amyloid protein in Alzheimer's disease

21 January 2018

1 reference

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

21 January 2018

1 reference

Clearance of amyloid beta-peptide from brain: transport or metabolism?

21 January 2018

1 reference

In vitro evidence that beta-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.10253

1 reference

12 May 2018

1 reference

12 May 2018